Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganmao Shuangjie granules for influenza (phase 3, China)
CTR20211709Phase 3Terminated
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ganmao Shuangjie Granules in influenza, sponsored by Yangtze River Pharmaceutical Group. Started Jul 2021; status: terminated.
02
Drugs
Ganmao Shuangjie Granules
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20211709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211709.